Development and Validation of a Nomogram to Predict the Future Risk of Cardiovascular Disease

被引:1
|
作者
Shen, Xuechun [1 ]
He, Wei [2 ]
Sun, Jinyu [3 ]
Zhang, Zuhong [1 ]
Li, Qiushuang [4 ]
Zhang, Haiyan [1 ]
Long, Mingzhi [1 ]
机构
[1] Nanjing Med Univ, Affiliated Hosp 2, Dept Cardiol, Nanjing 210011, Jiangsu, Peoples R China
[2] Nanjing Med Univ, Affiliated Hosp 2, Dept Geriatr, Nanjing 210011, Jiangsu, Peoples R China
[3] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing 210029, Jiangsu, Peoples R China
[4] Nanjing Bottests Biotechnol Co Ltd, Dept Technol, Nanjing 211112, Jiangsu, Peoples R China
关键词
biomarker; cardiac myosin-binding protein -C; cardiovascular disease; nomogram; risk prediction; CORONARY-HEART-DISEASE; MULTIPLE BIOMARKERS; 10-YEAR RISK; EVENTS; MORTALITY; SCORE;
D O I
10.31083/j.rcm2402035
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Early identification of individuals at a high risk of cardiovascular disease (CVD) is crucial. This study aimed to construct a nomogram for CVD risk prediction in the general population. Methods: This retrospective study analyzed the data between January 2012 and September 2020 at the Physical Examination Center of the Second Affiliated Hospital of Nanjing Medical University (randomized 7:3 to the training and validation cohorts). The outcome was the occurrence of CVD events, which were defined as sudden cardiac death or any death related to myocardial infarction, acute exacerbation of heart failure, or stroke. The least absolute shrinkage and selection operator (LASSO) method and multivariate logistic regression were applied to screen the significant variables related to CVD. Results: Among the 537 patients, 54 had CVD (10.1%). The median cardiac myosin-binding protein-C (cMyBP-C) level in the CVD group was higher than in the no-CVD group (42.25 pg/mL VS 25.00 pg/mL, p = 0.001). After LASSO selection and multivariable analysis, cMyBP-C (Odds ratio [OR] = 1.004, 95% CI [CI, confidence interval]: 1.000-1.008, p = 0.035), age (OR = 1.023, 95% CI: 0.999-1.048, p = 0.062), diastolic blood pressure (OR =1.025, 95% CI: 0.995-1.058, p = 0.103), cigarettes per day (OR =1.066, 95% CI: 1.021-1.113, p = 0.003), and family history of CVD (OR = 2.219, 95% CI: 1.003-4.893, p = 0.047) were associated with future CVD events (p < 0.200). The model, including cMyBP-C, age, diastolic blood pressure, cigarettes per day, and family history of CVD, displayed a high predictive ability with an area under the curve (AUC) of 0.816 (95% CI: 0.714-0.918) in the training cohort (specificity and negative predictive value of 0.92 and 0.96) and 0.774 (95% CI: 0.703-0.845) in the validation cohort. Conclusions: A nomogram based on cMyBP-C, age, diastolic blood pressure, cigarettes per day, and family history of CVD was constructed. The model displayed a high predictive ability.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Development and validation of a nomogram to predict the risk of constipation after lumbar interbody fusion surgery
    Chen, Mingxin
    Cheng, Si
    Zhong, Dian
    Hu, Tao
    Wang, Xin
    Deng, Zhongliang
    Yu, Qingshuai
    Yan, Zhengjian
    ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY, 2024, 144 (05) : 1907 - 1916
  • [22] Development and validation of nomogram to predict risk of survival in patients with laryngeal squamous cell carcinoma
    Cui, Jie
    Wang, Liping
    Zhong, Waisheng
    Chen, Zhen
    Tan, Xiaojun
    Yang, Hong
    Chen, Jie
    Liu, Genglong
    BIOSCIENCE REPORTS, 2020, 40
  • [23] Development and validation of a nomogram to predict the risk of constipation after lumbar interbody fusion surgery
    Mingxin Chen
    Si Cheng
    Dian Zhong
    Tao Hu
    Xin Wang
    Zhongliang Deng
    Qingshuai Yu
    Zhengjian Yan
    Archives of Orthopaedic and Trauma Surgery, 2024, 144 : 1907 - 1916
  • [24] Development and validation of a nomogram to predict intracranial haemorrhage in neonates
    Xu, Shuming
    Zhang, Siqi
    Hou, Qing
    Wei, Lijuan
    Wang, Biao
    Bai, Juan
    Guan, Hanzhou
    Zhang, Yong
    Li, Zhiqiang
    PEDIATRICS AND NEONATOLOGY, 2024, 65 (05): : 493 - 499
  • [25] Validation of a preeclampsia questionnaire to assess risk of future cardiovascular disease
    Diehl, Courtenay L.
    Brost, Brian C.
    Hogan, Marie C.
    Elesber, Ahmad A.
    Offord, Kenneth P.
    Turner, Stephen T.
    Garovic, Vesna D.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2007, 197 (06) : S113 - S113
  • [26] Development and validation of a pretreatment nomogram to predict disease-specific mortality in gastric cancer
    Bando, Etsuro
    Ji, Xinge
    Kattan, Michael W.
    Bencivenga, Maria
    De Manzoni, Giovanni
    Terashima, Masanori
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [27] A nomogram to predict the development of a nomogram
    Carden, Craig P.
    Rosenthal, Mark A.
    BJU INTERNATIONAL, 2008, 102 (03) : 402 - 402
  • [28] Development and external validation of a biopsy-derived nomogram to predict risk of ipsilateral extraprostatic extension
    Sayyid, Rashid
    Perlis, Nathan
    Ahmad, Ardalanejaz
    Evans, Andrew
    Toi, Ants
    Horrigan, Michael
    Finelli, Antonio
    Zlotta, Alexandre
    Kulkarni, Girish
    Hamilton, Robert
    Morash, Christopher
    Fleshner, Neil
    BJU INTERNATIONAL, 2017, 120 (01) : 76 - 82
  • [29] Development and validation of a nomogram to predict Chinese breast cancer risk based on clinical serum biomarkers
    Li, Nan
    Cao, Lingli
    Zhao, Kexin
    Feng, Yonghui
    BIOMARKERS IN MEDICINE, 2023, 17 (05) : 273 - 286
  • [30] Development and validation of a nomogram to predict the 30-day mortality risk of patients with intracerebral hemorrhage
    Zou, Jianyu
    Chen, Huihuang
    Liu, Cuiqing
    Cai, Zhenbin
    Yang, Jie
    Zhang, Yunlong
    Li, Shaojin
    Lin, Hongsheng
    Tan, Minghui
    FRONTIERS IN NEUROSCIENCE, 2022, 16